COPD News

Use of the antibiotic azithromycin on top of standard care may reduce treatment failure in high-risk patients hospitalized for an acute exacerbation of chronic obstructive pulmonary disease, according to new data from the BACE trial.

Only 1 in 10 patients with chronic obstructive pulmonary disease visited a pulmonologist within a 1-year period in Ontario, Canada, according to recent data published in Chest.

Patients with common lung diseases, including asthma, chronic obstructive pulmonary disease and lung fibrosis, are significantly more likely to develop cardiovascular disease, according to a study published in the Journal of the American College of Cardiology.

PHILADELPHIA — The role e-cigarettes play on tobacco dependence, the morbidity and potentially mortality from tobacco is “unclear,” a speaker said at the American College of Physicians Internal Medicine Meeting.

Oral vitamin D supplementation “safely and substantially” lowered the moderate/severe COPD exacerbation rates in patients with baseline 25-hydroxyvitamin D levels of less than 25 nmol/L, according to a systematic review and meta-analysis recently published in Thorax.

Increased severity of chronic obstructive pulmonary disease was associated with increased risk for hospitalization and mortality among patients with HF, according to findings published in JAMA Network Open.

The Ottawa COPD Risk Scale — which assessed a combination of 10 factors — ascertained which patients with COPD were more likely to have short-term serious outcomes better than current practice, according to findings recently published in the Canadian Medical Association Journal.

New persistent opioid use is becoming increasingly common among patients with inflammatory bowel disease, particularly for patients with mental health disorders and chronic obstructive pulmonary disease, according to research published in Alimentary Pharmacology & Therapeutics.

Long-term light smokers were at greater risk for obstructive lung disease, emphysema and lung function decline than heavy smokers who quit, according to findings recently presented at the American Thoracic Society 2018 International Conference.

Triple therapy administered once-daily in an inhaler reduced moderate or severe COPD exacerbations and improved lung function to a greater extent than dual therapy regimens, according to findings published in NEJM.